Apices integrates Kappa Sante into CRO business
Madrid, Spain-based CRO Apices has completed the integration of Paris, France-headquartered counterpart Kappa Sante.
The acquisition – financial terms of which were not disclosed – was prompted by Kappa Sante-use of artificial intelligence technology and a desire to expand across Europe according to Apices CEO, Oscar Salamanca.
“The incorporation of Kappa Santé into the Group is a major step in our plans for international growth as a company.
“In addition, the combined knowledge and experience of both companies strengthens our position in the market and boosts our growth, which will help us to solve more effectively the challenges of our clients in the study design, clinical development planning and the achievement of objectives to maximize the success of the projects.”
The integration means Apices has a staff of more than 100 staff who have worked on 450 clinical trials. This experience is likely to be an advantage in the current climate according to Salamanca.
“In an increasingly complex environment in which more and more elaborate studies are designed, having staff with more than 20 years of experience in clinical research in your team provides you with the confidence to achieve the planned objectives in each of the projects and to provide added value to our clients.”
This was echoed by Ana Moreno, global clinical operations director, who said, “Kappa Santé will allow us to reinforce our know-how and know-who and to continue carrying out clinical research projects efficiently, with the highest quality and always focused on meeting deadlines and customer satisfaction.
Apices also shared details of its post-integration plans, explaining it focus on searching for new clients, projects in new therapeutic areas and the use of new technologies that optimise clinical research.
The firm also left open the possibility of other acquisitions, writing that it does not “rule out the incorporation of new companies into the group that share the same philosophy.”
DepositPhotos/Mazirama